Home > News > pSivida signs licence with Beijing Med-Pharm
October 27th, 2005
pSivida signs licence with Beijing Med-Pharm
Abstract:
Global bio-nanotech company pSivida Limited is pleased to announce that it has signed a Licence with Beijing Med-Pharm Corporation for the clinical development, marketing and distribution of pSivida's lead product, BrachySilTM, in China.
Source:
biotech-intelligence.com
Bookmark:
| Related News Press |
Nanomedicine
Nanobiotix Publishes Positive Phase 2/3 Data For Nanomedicine in Soft Tissue Cancer (Webcast June 22) June 22nd, 2018
Collaboration yields discovery of 12-sided silica cages June 20th, 2018
Materials/Metamaterials
Making quantum puddles: Physicists discover how to create the thinnest liquid films ever June 13th, 2018
Nickel ferrite promotes capacity and cycle stability of lithium-sulfur battery June 13th, 2018
Evidence for a new property of quantum matter revealed: Electrical dipole activity detected in a quantum material unlike any other tested June 11th, 2018
Announcements
Nanobiotix Publishes Positive Phase 2/3 Data For Nanomedicine in Soft Tissue Cancer (Webcast June 22) June 22nd, 2018
Collaboration yields discovery of 12-sided silica cages June 20th, 2018
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||